The current board should be supported in its endeavours to appoint a new CEO. Now is not the time for board changes.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025